Astramorph pf and Intervertebral disc degeneration - a phase IV clinical study of FDA data

Summary:

Intervertebral disc degeneration is reported as a side effect among people who take Astramorph pf (morphine sulfate), especially for people who are male, 50-59 old, also take Lantus, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Intervertebral disc degeneration when taking Astramorph pf. It is created by eHealthMe based on reports of 69 people who have side effects when taking Astramorph pf from the FDA, and is updated regularly.

What is Astramorph pf?

Astramorph pf has active ingredients of morphine sulfate. eHealthMe is studying from 71 Astramorph pf users. Check the latest studies of Astramorph pf.

What is Intervertebral disc degeneration?

Intervertebral disc degeneration (spinal disc degeneration) is found to be associated with 1,312 drugs and 1,500 conditions by eHealthMe. Check the latest studies of Intervertebral disc degeneration.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 31, 2026

69 people reported to have side effects when taking Astramorph pf.
Among them, 17 people (24.64%) have Intervertebral disc degeneration.

Could Astramorph pf cause Intervertebral disc degeneration?

Among these 17 people:

What is the gender of people who have Intervertebral disc degeneration when taking Astramorph pf? *

female: 5.88 %
male: 94.12 %

What is the age of people who have Intervertebral disc degeneration when taking Astramorph pf? *

What are other drugs people take besides Astramorph pf? *

What are other side effects people have besides Intervertebral disc degeneration? *

Emotional Distress: 17 people, 100.00%
Myelitis Transverse (a neurological condition consisting of an inflammatory process of the spinal cord): 17 people, 100.00%
Pain: 17 people, 100.00%
Discomfort: 17 people, 100.00%
Depression: 17 people, 100.00%
Stress And Anxiety: 17 people, 100.00%
Deformity (disfigurement): 16 people, 94.12%
Injury: 16 people, 94.12%
Pleural Fibrosis (formation of fibrous tissue in lung): 16 people, 94.12%
Hypophagia (reduced food intake): 16 people, 94.12%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 17 people, 100.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.88%
Birth Control: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Astramorph pf and have Intervertebral disc degeneration?

- Check whether Intervertebral disc degeneration is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Browse all side effects of Astramorph pf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intervertebral disc degeneration:

Intervertebral disc degeneration (1,312 drugs)

Browse all the conditions that are associated with Intervertebral disc degeneration:

Intervertebral disc degeneration (1,500 conditions)

Related publications that referenced our studies

Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate (the active ingredients of Astramorph pf) and Astramorph pf (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.